Morgan Stanley lowers Torrid stock price target to $1.01 on product issues
NegativeFinancial Markets
- Morgan Stanley has lowered its stock price target for Torrid to $1.01, citing ongoing product issues that have negatively impacted the company's performance. This adjustment reflects a broader concern regarding Torrid's ability to navigate challenges in the retail market, particularly in light of a recent sales decline reported in its Q3 2025 earnings call.
- The reduction in the stock price target is significant for Torrid as it signals a lack of confidence from analysts in the company's future growth prospects. Investors may interpret this move as a warning sign, potentially leading to further declines in stock value and affecting investor sentiment.
- This development is part of a larger trend in the retail sector, where several companies, including Hims and Hers and Genesco, have also faced negative adjustments to their stock targets due to various operational challenges. The retail market is currently experiencing heightened scrutiny as companies struggle to maintain sales growth and profitability amidst increasing competition and changing consumer preferences.
— via World Pulse Now AI Editorial System
